Large-scale testing (Phase 3)Study completedNCT00647400What this trial is testingAdalimumab in Adult Japanese Subjects With PsoriasisWho this might be right forPsoriasis Abbott 147
Testing effectiveness (Phase 2)Looking for participantsNCT07013201What this trial is testingA 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar PustulosisWho this might be right forPalmoplantar Pustulosis LEO Pharma 135
Large-scale testing (Phase 3)Study completedNCT05536726What this trial is testingRecombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque PsoriasisWho this might be right forPsoriasis Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 458
Testing effectiveness (Phase 2)Study completedNCT03431974What this trial is testingOnce-Weekly Oral Aminopterin for the Treatment of Subjects With Moderate-To-Severe PsoriasisWho this might be right forPsoriasis Syntrix Biosystems, Inc. 19
Post-approval studies (Phase 4)Study completedNCT01077882What this trial is testingAnalysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic DermatitisWho this might be right forPsoriasisAtopic Dermatitis University Hospital, Ghent 50
Not applicableStudy completedNCT04433442What this trial is testingStudy to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic ArthritisWho this might be right forPsoriasisPsoriatic Arthritis AbbVie 2,324
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06562894What this trial is testingStudy to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata PatientsWho this might be right forSevere Alopecia Areata CSPC Ouyi Pharmaceutical Co., Ltd. 156
Large-scale testing (Phase 3)Study completedNCT02074982What this trial is testingEfficacy of Secukinumab Compared to Ustekinumab in Patients With Plaque-type PsoriasisWho this might be right forChronic Plaque Type Psoriasis Novartis Pharmaceuticals 676
Not applicableActive Not RecruitingNCT07244744What this trial is testingTilrdakizumab AlmirallWho this might be right forPsoriasis University Hospital Schleswig-Holstein 3
Post-approval studies (Phase 4)Study completedNCT00655564What this trial is testingLong-Term One Year Use of Alefacept (Amevive®) in Moderate to Severe Chronic Plaque Type PsoriasisWho this might be right forPsoriasis Wake Forest University 15
Post-approval studies (Phase 4)UnknownNCT03478280What this trial is testingEffect of Brodalumab Compared to Placebo on Vascular Inflammation in Moderate-to-severe PsoriasisWho this might be right forPsoriasis Aarhus University Hospital 50
Not applicableStudy completedNCT05959070What this trial is testingAn Observational Study to Validate the Cumulative Life Course Impairment (CLCI) Instrument (DermCLCI-p) in Adult Participants With Moderate to Severe Chronic Plaque Psoriasis (PsO)Who this might be right forPsoriasis AbbVie 154
Not applicableEnrolling By InvitationNCT03254667What this trial is testingLTS of Siliq vs. Other Therapies Treating of Adults With Moderate-to-Severe PsoriasisWho this might be right forPsoriasis Bausch Health Americas, Inc. 3,500
Post-approval studies (Phase 4)Study completedNCT04229836What this trial is testingEfficacy and Safety of Tildrakizumab 100 Milligrams (mg) in Participants With Moderate-Severe Chronic Plaque Psoriasis and Its Impact on Their Quality of Life (TRIBUTE)Who this might be right forPlaque Psoriasis Almirall, S.A. 178
Large-scale testing (Phase 3)Study completedNCT05108766What this trial is testingA Phase Ⅲ Study to Evaluate Tildrakizumab in the Treatment of Chinese Subjects With Moderate to Severe Plaquetype PsoriasisWho this might be right forPlaque Psoriasis Shenzhen Kangzhe Pharmaceutical Co., Ltd. 220
Testing effectiveness (Phase 2)Looking for participantsNCT07801495What this trial is testingAssess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic ArthritisWho this might be right forModerate to Severe Psoriatic Arthritis Novartis Pharmaceuticals 220
Large-scale testing (Phase 3)Study completedNCT07712705What this trial is testingHPP737 in Adult Patients With Moderate-to-severe Plaque Psoriasis.Who this might be right forPsoriasis Newsoara Biopharma Co., Ltd. 515
Testing effectiveness (Phase 2)Study completedNCT05858047What this trial is testingAn Investigational Study to Evaluate Experimental Medication SYHX1901 Tablets With Moderate to Severe Plaque PsoriasisWho this might be right forEffects, Drug Side CSPC Ouyi Pharmaceutical Co., Ltd. 93
Large-scale testing (Phase 3)Study completedNCT02748863What this trial is testingStudy of Secukinumab With 2 mL Pre-filled SyringesWho this might be right forPsoriasis Novartis Pharmaceuticals 214
Large-scale testing (Phase 3)Study completedNCT01186744What this trial is testingEvaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque PsoriasisWho this might be right forPsoriasis Pfizer 666